Solvay Shares Drop 2.75% and Approach Key Technical Support
Solvay's stock significantly retreated this Thursday morning, falling 2.75% to 25.50 euros in early trading hours. This decline is part of a broader pullback across European markets, with the CAC 40 dropping 1.64% during the session. The Belgian chemical company's stock is now nearing its technical support level, following a year of continuous deterioration.
In this Thursday morning's session, Solvay is trading at 25.50 euros, just cents away from its identified support threshold at 25.46 euros. This level represents a major vigilance zone: a downward breach could pave the way for further decline. The stock is now trading significantly below its 20, 50, and 200-day moving averages, which are positioned at 26.63, 26.61, and 27.59 euros respectively, confirming a bearish trend that has been in place for several months. The RSI, an indicator measuring the momentum of a stock over recent sessions, is at 35, a level that indicates significant selling pressure without yet reaching the oversold zone (below 30). The most relevant resistance is positioned at 28.50 euros, more than 11% above the current price, illustrating the magnitude of the recovery needed for a potential bullish reversal. Over one year, the performance remains poor: the stock has declined by 28.31%, reflecting a significant erosion of the group's market valuation.
General Correction Movement in Europe
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
This Thursday's session is characterized by a generalized correction movement across Europe. The CAC 40 is down 1.64% at 7,838.95 points, while the SBF 120 has dropped 1.65%. Solvay's decline, more pronounced than that of the indices, also exceeds the falls seen in other major industrial capitalizations listed in Paris. Schneider Electric is down 3.26% and Airbus has fallen 2.81%, but these stocks operate in sectors distinct from specialty chemicals. On the calendar front, the group's next quarterly results are expected on May 7, followed by the annual general meeting scheduled for May 12. These events could provide updated insights into the company's operational and financial trajectory, at a time when the stock suffers from a cumulative decline of 4.78% over three months. The monthly volatility of the stock remains contained at 8.35%, while its nearly zero beta (-0.02) indicates a low historical correlation with overall market movements.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
